Ondine Biomedical Inc. (AIM: OBI)
6.38
-0.38 (-5.56%)
Sep 10, 2024, 4:14 PM GMT+1
Ondine Biomedical Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2010 | 2009 - 2005 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '10 Dec 31, 2010 | 2009 - 2005 |
Cash & Equivalents | 2.98 | 2.98 | 13.13 | 30.37 | 0.63 | 0.88 | Upgrade
|
Cash & Short-Term Investments | 2.98 | 2.98 | 13.13 | 30.37 | 0.63 | 0.88 | Upgrade
|
Cash Growth | -77.29% | -77.29% | -56.78% | 4750.64% | -28.58% | -16.98% | Upgrade
|
Accounts Receivable | 0.32 | 0.32 | 0.13 | 0.16 | 0.54 | 0.26 | Upgrade
|
Other Receivables | 0 | 0 | 0.05 | 0.09 | 0.01 | - | Upgrade
|
Receivables | 0.33 | 0.33 | 0.18 | 0.25 | 0.54 | 0.26 | Upgrade
|
Inventory | 1.07 | 1.07 | 1.29 | 1.06 | 0.4 | 0.23 | Upgrade
|
Prepaid Expenses | 0.22 | 0.22 | 0.38 | 1.83 | 0.17 | 0.28 | Upgrade
|
Restricted Cash | 0.16 | 0.16 | 0.15 | - | - | - | Upgrade
|
Total Current Assets | 4.75 | 4.75 | 15.13 | 33.5 | 1.75 | 1.64 | Upgrade
|
Property, Plant & Equipment | 0.95 | 0.95 | 1.4 | 0.6 | 0.67 | 0.48 | Upgrade
|
Other Intangible Assets | - | - | - | - | 0.17 | 0.41 | Upgrade
|
Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | - | Upgrade
|
Total Assets | 5.73 | 5.73 | 16.57 | 34.14 | 2.64 | 2.53 | Upgrade
|
Accounts Payable | 1.36 | 1.36 | 0.39 | 1.2 | 0.77 | 1.4 | Upgrade
|
Accrued Expenses | 1.75 | 1.75 | 3.16 | 2.08 | 0.64 | - | Upgrade
|
Short-Term Debt | - | - | - | - | 26.99 | 0.5 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 7.16 | - | Upgrade
|
Current Portion of Leases | 0.38 | 0.38 | 0.36 | 0.15 | 0.23 | - | Upgrade
|
Current Income Taxes Payable | - | - | - | - | - | 0 | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 0.2 | Upgrade
|
Other Current Liabilities | - | - | - | 0.5 | - | 0 | Upgrade
|
Total Current Liabilities | 3.49 | 3.49 | 3.91 | 3.92 | 35.79 | 2.11 | Upgrade
|
Long-Term Debt | - | - | 0.48 | 0.47 | 0.59 | - | Upgrade
|
Long-Term Leases | 0.16 | 0.16 | 0.54 | 0.09 | 0.09 | - | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | - | 0.15 | Upgrade
|
Total Liabilities | 3.65 | 3.65 | 4.93 | 4.48 | 36.46 | 2.25 | Upgrade
|
Common Stock | 239.65 | 239.65 | 235.04 | 235.04 | 119.53 | 55.9 | Upgrade
|
Additional Paid-In Capital | 10.53 | 10.53 | 10.53 | 10.53 | 10.38 | 6.32 | Upgrade
|
Retained Earnings | -266.33 | -266.33 | -251.92 | -232.54 | -182.14 | -61.94 | Upgrade
|
Comprensive Income & Other | 18.24 | 18.24 | 18 | 16.64 | 18.42 | - | Upgrade
|
Total Common Equity | 2.09 | 2.09 | 11.64 | 29.66 | -33.81 | 0.28 | Upgrade
|
Minority Interest | - | - | - | - | -0.01 | - | Upgrade
|
Shareholders' Equity | 2.09 | 2.09 | 11.64 | 29.66 | -33.83 | 0.28 | Upgrade
|
Total Liabilities & Equity | 5.73 | 5.73 | 16.57 | 34.14 | 2.64 | 2.53 | Upgrade
|
Total Debt | 0.54 | 0.54 | 1.38 | 0.71 | 35.05 | 0.5 | Upgrade
|
Net Cash (Debt) | 2.44 | 2.44 | 11.75 | 29.66 | -34.43 | 0.38 | Upgrade
|
Net Cash Growth | -79.23% | -79.23% | -60.39% | - | - | -64.33% | Upgrade
|
Net Cash Per Share | 0.01 | 0.01 | 0.06 | 0.37 | -0.49 | 0.05 | Upgrade
|
Filing Date Shares Outstanding | 226.75 | 226.75 | 194.59 | 194.58 | 70.67 | 9.66 | Upgrade
|
Total Common Shares Outstanding | 226.75 | 226.75 | 194.59 | 194.58 | 70.67 | 9.57 | Upgrade
|
Working Capital | 1.26 | 1.26 | 11.22 | 29.58 | -34.04 | -0.47 | Upgrade
|
Book Value Per Share | 0.01 | 0.01 | 0.06 | 0.15 | -0.48 | 0.03 | Upgrade
|
Tangible Book Value | 2.09 | 2.09 | 11.64 | 29.66 | -33.99 | -0.13 | Upgrade
|
Tangible Book Value Per Share | 0.01 | 0.01 | 0.06 | 0.15 | -0.48 | -0.01 | Upgrade
|
Machinery | 0.99 | 0.99 | 1.95 | 1.77 | 1.69 | 1.58 | Upgrade
|
Leasehold Improvements | 0.31 | 0.31 | 0.29 | 0.28 | 0.28 | 0.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.